Tikehau IM is to invest EUR72 million in the Dedalus Group, a clinical health software provider, controlled by Ardian and company founder Giorgio Moretti.
Tikehau IM has acted as sole arranger of a bond issuance which will be listed on the third market of the Vienna Stock Exchange. This is the third direct lending deal executed by the Tikehau IM team in Italy.
Dedalus is headquartered in Florence, Italy. In line with its strategy of external growth, Dedalus has acquired 40 companies to date and made significant investments in R&D to become a global company and a leading player in the field of clinical health software. Its merger with NoemaLife earlier this year created the first operator in Italy in the hospital information systems market and one of the first players in Europe, with global activities in 25 countries. The group expects to close 2016 with a turnover exceeding EUR170 million.
Giorgio Moretti, founder and CEO of Dedalus, says: “In Europe and globally, our industry is going through a consolidation wave. Thanks to increased financial resources, a large customer base and a strong international presence, Dedalus is able to remain a leading player of this industry. We greatly appreciated Tikehau’s deep understanding of our business, their ability to quickly complete this transaction and we would like to thank them for supporting us in our ambition to further grow internationally.”
Luca Bucelli, head of Italy at Tikehau IM, says: “This transaction illustrates Tikehau Capital’s commitment to invest in Italy and its capacity to provide tailor-made financing solutions to support fast growing businesses. We are enthusiastic about the opportunity to work alongside Giorgio Moretti and Ardian in this new chapter of Dedalus growth strategy.”
